Leigh Zawel Cullinan Oncology, Inc. (CGEM) insider trading activity

Leigh Zawel is Officer of Cullinan Oncology, Inc.. Currently has a direct ownership of 69,785 shares of CGEM, which is worth approximately $1.1 Million. The most recent transaction as insider was on Feb 11, 2022, when has been sold 32,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.8K

0% 3M change

0% 12M change

Total Value Held $1.1 Million

Leigh Zawel Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 11 2022	BUY Grant, award, or other acquisition	-	32,500 Added 31.77%	69,785 Common Stock
Oct 15 2021	SELL Open market or private sale	$489,350 $25.0 p/Share	19,574 Reduced 34.43%	37,285 Common Stock
Oct 07 2021	SELL Open market or private sale	$26,975 $25.0 p/Share	1,079 Reduced 1.86%	56,859 Common Stock
Sep 20 2021	SELL Open market or private sale	$187,895 $25.16 p/Share	7,468 Reduced 11.42%	57,938 Common Stock
Sep 07 2021	SELL Open market or private sale	$814,016 $28.95 p/Share	28,118 Reduced 30.07%	65,406 Common Stock
Aug 23 2021	SELL Open market or private sale	$815,422 $29.0 p/Share	28,118 Reduced 23.12%	93,524 Common Stock
Aug 10 2021	SELL Open market or private sale	$189,720 $27.44 p/Share	6,914 Reduced 5.38%	121,642 Common Stock
Aug 09 2021	SELL Open market or private sale	$568,691 $26.82 p/Share	21,204 Reduced 14.16%	128,556 Common Stock

Leigh Zawel

Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGEM shares.

Notify only if

Value

Insider Trading

Get notified when an Cullinan Oncology, Inc. insider buys or sells CGEM shares.

Notify only if

Operation

Value

Type

News

Receive news related to Cullinan Oncology, Inc.

Track Activities on CGEM

Account